Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-24-085096

Chief Executive Officer acquired 13,797 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Collard Craig A Chief Executive Officer 2024-07-19 Option exercise +13,797 276,590 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Collard Craig A Chief Executive Officer 2024-07-19 Option exercise · Restricted Stock Units −13,797 193,156 D: show line 2 in the form
Loading xslF345X05/ownership.xml…